A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive
Clinical trial NCT05007080 · COMPLETED
Trial details
- NCT number
- NCT05007080
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2023-08-14
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.